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Background: There are only a few studies of the prevalence of dementia in 
people with intellectual disability (ID) without Down syndrome (DS), and there 
is a large difference in the prevalences between reported studies. Moreover, the 
prevalence of mild cognitive impairment (MCI) in ID has not been reported. We 
aimed to evaluate the prevalence of dementia in adults of all ages and the 
prevalence of MCI in people with ID. Further, we tried to clarify the differences 
depending on the various diagnostic criteria. 
Methods: The survey included 493 adults with intellectual disability at 28 
facilities in Japan. The caregivers answered a questionnaire, and physicians 
directly examined the participants who were suspected of cognitive decline. 
Dementia and MCI were diagnosed according to ICD-10, DC-LD, and DSM-5 
criteria. 
Results: The prevalence of dementia was 0.8% for the 45–54 year old group, 
3.5% for the 55–64 year old group, and 13.9% for the 65–74 year old group in 
people with ID wihout DS. The prevalence of MCI was 3.1% for patients 45–54, 
3.5% for patients 55–64, and 2.8% for patients 65–74 with ID wihout DS. 
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DSM-5 was the most inclusive in diagnosing dementia and MCI in people with 
ID. 
Conclusions: People with ID without DS may develop dementia and MCI at an 
earlier age and higher rate than the general population. Among the diagnostic 
criteria, DSM-5 was the most useful for diagnosing their cognitive impairment. 
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Key points 
⚫ There are only a few studies of the prevalence of dementia and mild 
cognitive impairment (MCI) in people with intellectual disability (ID) 
without Down syndrome (DS). 
⚫ This study investigated 493 adults with ID. The physicians directly 
examined the participants suspected of cognitive decline and diagnosed 




⚫ The prevalence of dementia in people with ID without DS may be higher 
than in the general population. DSM-5 was more inclusive in diagnosing 





The average life expectancy of people with intellectual disability (ID) has 
increased remarkably in recent years, and not a few people with ID live to over 
the age of 65.1 Along with the aging of people with ID, the problem of dementia 
in people with ID has become important.2 However, it is not easy to screen for 
dementia in people with ID. Screening tests for dementia in the general 
population such as the Mini Mental State Examination (MMSE) are not useful 
for screening for dementia in the ID population.3 As one reason, most people 
with ID have difficulty in achieving more than the cut-off score on the screening 
tests even before the appearance of cognitive deterioration.4 In addition, people 
with ID have various degrees of pre-existing cognitive impairment, and there 
are generally no reference data or thresholds for screening tests of dementia in 
ID.5,6 In order to diagnose dementia in people with ID, it is necessary to 
compare the present state of their cognitive function and daily living activities 
with their highest level in the past. Therefore, we need information from family 
members or care staff who have known the person with ID for a long time.7,8 
Because it takes much time and effort, there are not many epidemiological 
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studies of dementia in people with ID. From the viewpoint of dementia in 
people with ID, Down syndrome (DS) has attracted much attention for a long 
time. DS, trisomy 21, is a genetic disorder, and the most common cause of ID 
among people whose causes are known.9 It is well known that people with DS 
suffer from Alzheimer disease dementia frequently after the age of 40 due to 
overload of amyloid beta protein.10 On the other hand, it is not clear whether the 
frequency of dementia in people with ID who do not have DS is higher than that 
in the general population. In the past 30 years, only two studies have been done 
to investigate the prevalence of dementia by age in people with ID without DS, 
and no unified conclusion on the prevalence of dementia in people with ID 
without DS has been reached. Zigman et al. reported that the prevalence of 
dementia in people with ID without DS is similar to that in the general 
population in New York State.11 On the other hand, Strydom et al. showed that 
the prevalence of dementia in people with ID without DS is higher than that in 
the general population in London.12,13 Various differences in the survey methods 
adopted in those studies are thought to affect the differences in the results.14 The 
differences of methods include study design (cross-sectional or longitudinal), 
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residential environment (community- or institution-based), subjects (inclusion 
or exclusion of DS), diagnostic method (physician’s diagnosis or chart record), 
and diagnostic criteria (clinical diagnosis or using diagnostic criteria).11-13,15-17 In 
order to clarify the prevalence of dementia and mild cognitive impairment 
(MCI) in an ID population without DS, we conducted an epidemiological 




2 MATERIALS AND METHODS 
2.1 Ethics 
This study was approved by the Internal Ethical Committee of the Okayama 
University Graduate School of Medicine, Dentistry, and Pharmaceutical 
Sciences (1708-044) and Asahigawaso Research Institute. This study was 
registered at The University Hospital Medical Information Network Clinical 
Trials Registry (UMIN000028708) on 11 November 2017. We provided all 
participants with simple written explanations of this research, taking into 
consideration the cognitive impairment of participants. After giving a complete 
description of the study to the subjects and their relatives, written informed 
consent was obtained from the subjects who were judged to have the ability to 
express consent. In addition, written informed consent was obtained from their 
relatives in all cases. 
 
2.2 Participants 
In the studies performed in Europe and the United States, researchers recruited 
participants using registration data managed by local governments and 
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conducted a survey on the prevalence of dementia in people with ID.11,12 On the 
other hand, people with ID are not registered in Japan. Therefore, we conducted 
an epidemiological survey at many support facilities that provide services for 
people with ID in Okayama Prefecture. Okayama is a prefecture of Japan 
located in the western region of the main island. Pariticipants were recruited 
from the users of the support facilities in November 2017 according to the 
following criteria. In total, 28 support facilities agreed to participate. Facility 
residents and home-based residents using day service at facilities were included, 
and the subjects fulfilled the following inclusion criteria. (i) The subject was 
diagnosed with intellectual disbility according to the criteria formulated by 
ICD-10: a condition of reduced overall level of intelligence (IQ<70) that 
manifested during the developmental period.18 (ii) There were information 
providers who had observed the living condition of the subject for two years or 
more, and the information providers agreed to respond to the interview and 
answer the questionnaire survey. (iii) Informed consent was obtained from 
participants who had the capacity to consent and the relatives of all participants.  
(iv) The subject was 20 years or older. (v) Down syndrome was identified from 
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records of chromosomal analysis or by their characteristic features.14  
 
2.3 Screening 
We designated the service providers who were involved with participants for 
more than two years and who knew the changes in the daily living activities of 
participants as ‘informants’. All informants completed the Japanese version of 
the Dementia Screening Questionnaire for Individuals with Intellectual 
Disabilities (DSQIID).19 In addition, they completed the Japanese version of the 
Physical Self-Maintenance Scale (PSMS) and Lawton’s Instrumental Activities 
of Daily Living Scale (IADL) as performance-based measures of activities of 
daily living.8,20 Three professional physicians interviewed all the informants in 
person, and they recorded detailed information of each participant over the past 
few years. The three physicians were STa (geriatric psychiatrist), STe (specialist 
on dementia), and RK (geneticist). The doctors judged participants who 
satisfied one or more of the two following conditions as screening positive: (i) 
at least one of the three doctors suspected the possibility that the cognitive 
function and/or ADL of the participant had deteriorated in the past few years, 
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and (ii) worsening of the score of PSMS or IADL in the past few years was 
recognized. The three doctors examined everyone who was positive in the 
screening. Any disagreement on diagnosis between the three doctors was settled 
by discussion. 
 
2.3.1 Dementia Screening Questionnaire for Individuals with Intellectual 
Disabilities (DSQIID) 
DSQIID is an observer-rated dementia screening questionnaire that is 
completed by carers who have known the subject for at least six months.8 
DSQIID was developed on the assumption that it would be used for adults with 
ID. Although the validity of DSQIID was evaluated only in adults with DS, the 
authors assert that DSQIID can be equally useful in ID adults without DS.8 The 
DSQIID consists of 53 items. The DSQIID comprehensively reflect symptoms 
of dementia, including cognitive functions such as loss of memory and speech 





2.3.2 Physical Self-Maintenance Scale (PSMS)  
PSMS is an informant-reported measure to evaluate the level of basic activities 
of daily living. Each of six basic activities of daily living (toileting, feeding, 
dressing, grooming, ambulation, and bathing) is rated 0–1 point. The maximum 
PSMS score is 6 points.20  
 
2.3.3 Lawton’s Instrumental Activities of Daily Living Scale (IADL) 
The IADL scale was developed to assess the more complex activities necessary 
for functioning in community settings. Each of eight activities (e.g. shopping 
and cooking) is rated 0–1 point.20 Three tasks, cooking, housekeeping, and 
laundry, were scored only for females in the original IADL. For this reason, the 
maximum score of the original IADL was 8 for females and 5 for males. In this 
study, the IADL scores of males were calculated by multiplying the original 
IADL score x 1.6. Therefore, in this study, the IADL has a maximum score of 8 





In diagnosing dementia, we used three criteria: ICD-10 Research Diagnostic 
Criteria (World Health Organization) for dementia, Diagnostic Criteria for 
Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental 
Retardation (DC-LD) (Royal College of Psychiatrists) for dementia, and 
DSM-5 criteria (American Psychiatric Association) for neurocognitive 
disorder.7,18,21 We used ICD-10 Research Diagnostic Criteria for mild cognitive 
disorder and DSM-5 criteria for mild neurocognitive disorder as diagnostic 
criteria for MCI. We diagnosed a participant who satisfied at least one of these 
criteria with dementia or MCI. We used the National Institute on 
Aging-Alzheimer's Association workgroups (NIA-AA) criteria for Alzheimer's 
disease (AD) dementia, the American Heart Association/American Stroke 
Association (AHA/ASA) criteria for vascular dementia (VaD), the 2017 
Consortium on Dementia with Lewy Bodies (DLB) criteria for DLB, and the 
International Consensus Criteria for Behavioural Variant FTD (FTDC) for 
behavioral variant FTD.22-25 
 
2.5 Statistical analysis 
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Statistical analysis was performed using the SPSS 24.0 J software program 
(SPSS Inc., Chicago, IL). Comparisons between two groups were performed by 
independent sample t-tests. Chi-square tests were used to analyse categorical 
variables with continuity correction for 2×2 tables. The significance level was 




3.1 Demographic and clinical features 
There were 909 users of the facilities. Of these, 118 of 909 (13.0%) cases were 
excluded from the study because they were less than 20 years old or they did 
not have ID but a mental disorder. The remaining 791 cases were potential 
participants. Of 791 subjects, 493 (62.3%) agreed to participate. Of 493 
participants, 34 (6.9%) were people with ID with DS, and 459 (93.1%) were 
people with ID without DS. The mean age of all the participants was 46.57 (SD: 
11.43 years; range: 19–83 years). The prevalences of current psychiatric 
disorders were: autism spectrum disorder, 92 (18.7%); psychiatric symptoms 
related to epilepsy, 9 (1.8%); schizophrenia, 5 (1%); bipolar disorder, 3 (0.6%); 
obsessive-compulsive disorder, 1 (0.2%); and others, 13 (2.6%). The mean age 
of 34 participants with DS was 39.41 (SD: 13.93 years; range: 20–65 years).  
 
3.2 Participants of dementia and MCI 
Seven of 34 (20.6%) participants with Down syndrome had dementia. All seven 
patients were classified as probable AD dementia. Cases of dementia have been 
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seen from the age of 45 years. There were no participants with DS diagnosed 
with MCI. The mean age of 459 participants without DS was 47.10 (SD: 13.98 
years; range: 20–83 years). Ten of 459 (2.2%) participants had dementia. Six 
out of 10 (60.0%) patients with dementia were classified as probable AD 
dementia, two (20.0%) as probable VaD, and two (20.0%) as possible AD 
dementia and possible DLB. Nine of 459 (2.0%) had MCI. The age-specific 
prevalences of dementia and MCI are shown in Table 1. With regard to the 
severity of ID, there were no patients with dementia and MCI among the 
participants who were rated as having mild ID. Two of 135 (1.5%) people with 
moderate ID and 15 of 298 (5.0%) people with severe ID were diagnosed with 
dementia. Four of 135 (3.0%) people with moderate ID and 5 of 298 (1.7%) 
people with severe ID were diagnosed with MCI (Table 2). 
 
3.3 Diagnosis of dementia and MCI, differences by diagnostic criteria 
Seventeen of all participants met the criteria for dementia of at least one of 
DSM-5, ICD-10, or DC-LD. All 17 dementia patients met the DSM-5 criteria, 
14 (82.4%) met the DC-LD criteria, and 13 (76.5%) met the ICD-10 criteria. 
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Seven of 17 dementia patients were people with DS, and they met the criteria 
for dementia of all three (DSM-5, ICD-10, and DC-LD). Ten of 17 (58.8%) 
dementia patients were people without DS, and they met the criteria of one or 
more of DSM-5, ICD-10, or DC-LD for dementia. All 10 patients met the 
DSM-5 criteria, 7 (70.0%) met the DC-LD criteria, and 6 (60.0%) met the 
ICD-10 criteria. Nine participants met at least one of the DSM-5 or ICD-10 
criteria for MCI. All nine patients diagnosed with MCI were people without DS; 





4.1 Prevalence of dementia and MCI in people with intellectual disability 
When discussing studies on the prevalence of dementia in people with ID, it is 
necessary to classify them into studies targeting people with ID with DS and 
studies targeting people with ID without DS. In this study, people with DS over 
the age of 45 had a high rate of dementia. The prevalence of dementia in people 
with DS was significantly higher than that in the general population, as reported 
in many previous studies in Europe, the United States, and Japan.26-28 There 
have been a few studies on the prevalence of dementia in people with ID 
without DS, although the number of those studies is lower than the number of 
studies on the prevalence of dementia in people with DS. Figure 1 shows the 
results of the previous studies and this study. For reference, we compared the 
result of our study (65–74 years, 13.9%) with the results of a large-scale 
epidemiological study targeting the general elderly population in Japan (65–74 
years, 4.2%), and found that the prevalence of dementia in people with ID 
without DS is high in the young age group.29 There are large differences 
between the dementia prevalences in several studies. Strydom et al. reported 
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that the prevalence of dementia in people with ID without DS was 2–3 times 
higher than that in the general population, whereas Zigman et al.11-13 reported 
that there was no difference in the prevalence of dementia between the ID 
population without DS and the general population. The prevalence in our 
research is roughly in the middle of these two studies. The major difference 
between the study of Strydom et al. and ours is estimated to be due to selection 
bias.12-13 Although both studies included facility residents and home-based 
residents using a day service, Strydom et al. recruited the participants from a 
service for people with ID and a medical service for elderly people. On the 
other hand, we recruited the participants from a service for people with ID only. 
Furthermore, in Japan, people who need nursing care and are unable to remain 
in a facility for people with ID are moved to a facility dedicated to the elderly. 
Among those who withdraw from facilities for people with ID in a year, 30.9% 
are due to death and 22.2% are due to movement to hospitals and facilities for 
elderly patients.30 Therefore, in this study, there is a possibility that the 
evaluated prevalence of dementia was lower than the actual, especially in the 
elderly age band. 
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Further, in this study, there is the contradiction that the prevalence of 
dementia is lower in the elderly group than in the younger group from the age of 
65 to 84. The prevalence of dementia is lower at 75–84 years (8.3%, n=12) 
compared to 65–74 years (13.9%, n=36) (Table 1). The cause of this 
contradiction is presumed to be selection bias as well. The cases of dementia 
needing nursing care tend to move from a facility for people with ID to a 
facility for the elderly. In this study, it is presumed that the prevalence of 
dementia in the age group older than 75 years was lower than in the younger 
age band for this reason. The major difference between the study of Zigman et 
al. and ours is the methods to detect dementia.11 Silverman et al. said that the 
cause of the difference between the study of Strydom et al. and that of Zigman 
et al. is the different methods used to evaluate and classify cases.31 In our 
research, we classified dementia based on defined diagnostic criteria such as 
ICD-10 and DSM-5, and this method is similar to the study of Strydom et al.12 
On the other hand, Zigman et al. did not classify dementia based on defined 
diagnostic criteria, and they limited dementia cases to Alzheimer’s disease.11 
The cause of the lower prevalence in the study of Zigman et al. than our study 
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may derive from the difference in diagnostic methods. Unlike previous studies 
that were limited to the elderly over 65 years, this study investigated all age 
groups from the age of 20 years. Although the number is small, it was found 
that dementia and MCI first occurred in the late forties.  
 
4.2 Differences according to diagnostic criteria for dementia and MCI 
Because the concept of dementia depends on the criteria, the prevalence of 
dementia in the general population varies depending on the diagnostic criteria of 
dementia.32,33 Some cross-sectional studies have reported that the prevalence of 
dementia defined by DSM-5 is higher than that by DSM-IV. 34,35 Even in people 
with ID, the prevalence varies with variations of criteria.12,36 In a previous study, 
three diagnostic criteria for dementia (DSM-IV, DC-LD, ICD-10) were used.12 
Strydom et al. reported some cases with no duplication of multiple diagnostic 
criteria, and ICD-10 dementia criteria missed dementia cases of moderate 
severity in this population.12 For this reason, we used three diagnostic critera for 
dementia (DSM-5, DC-LD, ICD-10). As a result, the number of dementia cases 
covered by each diagnostic criterion differed, and DSM-5 was able to diagnose 
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the most cases (Figure 2). Memory impairment is essential for diagnosis in 
ICD-10 or DC-LD, but it was difficult to confirm the function of memory in 
some cases due to difficulties in conversations and activities. On the other hand, 
memory impairment is not indispensable in DSM-5. It is possible to diagnose 
dementia using DSM-5 based on the decline of one of multiple cognitive 
domains (Table 3). It has been reported that DSM-5 can detect more cases of 
dementia without memory impairment, language impairment, and decline of 
instrumental activities of daily living (IADL) than DSM-IV. 34 To extensively 
diagnose dementia in people with ID, DSM-5 may be suitable. For the diagnosis 
of MCI, we used DSM-5 and ICD-10. DSM-5 diagnosed more MCI cases than 
ICD-10. As one reason, impairment of executive function is essential for 
diagnosis in ICD-10, but it was difficult to confirm in people with severe ID. 
 
4.3 Difference in prevalence of dementia and MCI due to severity of ID 
Regarding the severity of mental retardation and the risk of developing 
dementia, Strydom et al. has said the prevalence of dementia was not influenced 
by ID level.14 On the other hand, many of the cases of dementia were found in 
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patients with severe ID, followed by many cases with moderate ID, but 
dementia was not observed in patients with mild ID in this study. As in the study 
of Strydom et al., there is no significant difference in the median age between 
the three groups with severe, moderate, and mild ID in this study. Strydom et al. 
mentioned that potential cases that did not have sufficient information for 
diagnosis were more common in participants with severe ID compared to mild 
or moderate ID.14 The more severe the ID, the more difficult it is to evaluate the 
objective cognitive function. Strydom et al. used ICD-10 and DSM-IV as 
diagnostic criteria.14 In diagnosing dementia using these criteria, unlike DSM-5, 
confirmation of memory impairment is indispensable. Even in the study by 
Strydom et al., it may have been possible to diagnose dementia in more cases 
using DSM-5.14 The cognitive reserve hypothesis that people with lower brain 
reserve are more likely to develop dementia has been long proposed.37 
Therefore, it is not surprising that the prevalence of dementia increases as the 





There are two limitations to this study. Firstly, there is possibility that this 
sample does not reflect the general population of people with ID precisely. 
Since there was no other way to recruit a large group of people with ID, we 
recruited in facilities for ID in this study. However, if there is a database in 
which all people with ID in the area are registered, it is best to conduct surveys 
based on those databases. There may be some people with ID do not use this 
type of social service. The reason why we did not have a participant over the 
age of 85 in this study may be because they had been moved to facilities for the 
elderly with dementia. In Japan, which service is used by elderly people with ID 
is decided case by case. Second, this study is a cross-sectional assessment, 
which is less reliable than a longitudinal assessment. It is desirable to evaluate 




In summary, this is the first study of people with ID without DS to investigate 
the prevalence of dementia and to report the prevalence of MCI by age. People 
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with ID without DS may develop dementia and MCI at an earlier age and higher 
rate than the general population. DSM-5 is thought to be the most useful among 
ICD-10, DC-LD, and DSM-5 in diagnosing dementia in people with ID, and 
DSM-5 is more useful than ICD-10 for diagnosing MCI. ICD-10 and DC-LD 
require a decline of specific cognitive domains such as memory and executive 
function, but DSM-5 can diagnose dementia and MCI based on a single decline 




Data Availability Statement 
The data that support the findings of this study are available from the 
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Table 1.  Demographic details of participants
Demographic All participants DS without DS p
Total (n) 493 34 459
Age (mean years ± SD) 46.57±14.09 39.41±13.93 47.10±13.98 <0.010
20-44 212 21 191
45-54 141 7 134
55-64 90 4 86
65-74 38 2 36
75-84 12 0 12
Sex (n) (male/female) 311/182 18/16 293/166 0.204
Education (mean years ± SD) 10.10±2.52 10.36±3.36 10.08±2.45 0.241
Type of residence
Independent or group home (n) (%) 201 (40.7) 19 (55.9) 182 (39.7)
Facility residents (n) (%) 292 (59.3) 15 (44.1) 277 (60.3)
Severity of ID
Mild ID (n) (%) 60 (12.2) 2 (5.9) 58 (12.6) 0.245
Moderate ID (n) (%) 135 (27.4) 12 (35.3) 123 (26.8) 0.284
Severe ID (n) (%) 298 (60.4) 20 (58.8) 278 (60.6) 0.841
DSQIID (mean ± SD) 2.50±5.89 7.68±13.29 2.11±4.71 <0.010
PSMS (mean ± SD) 2.48±1.91 2.18±1.69 2.51±1.92 0.390
IADL (mean ± SD) 1.87±1.77 2.07±1.68 1.85±1.78 0.560
Psychiatric disorders (n) (%) 124 (25.2) 1 (2.9) 123 (26.8) <0.010
Epilepsy (n) (%) 175 (35.5) 4 (11.8) 171 (37.3) <0.010
Visual probrems (n) (%) 19 (3.9) 0 (0) 19 (4.1) 0.633
Hearing problems (n) (%) 12 (2.4) 4 (11.8) 8 (1.7) <0.010
Mobidity problems (n) (%) 59 (12.0) 3 (8.9) 56 (12.2) 0.785
Dementia (n) (%)
20-44 0 (0) 0 (0) 0(0) -
45-54 4 (2.8) 3 (42.9) 1 (0.8) <0.010
55-64 5 (5.6) 2 (50.0) 3 (3.5) <0.010
65-74 7 (18.4) 2 (100.0) 5 (13.9) <0.010
75-84 1 (8.3) - 1 (8.3) -
MCI (n) (%)
20-44 0 (0) 0 (0) 0 (0) -
45-54 4 (2.8) 0 (0) 4 (3.1) -
55-64 3 (3.3) 0 (0) 3 (3.5) -
65-74 1 (2.6) 0 (0) 1 (2.8) -
75-84 1 (8.3) - 1 (8.3) -
SD, standard deviation; ID, intellectual disability; DS/without DS, subjects with Down syndrome and without Down
syndrome; DSQIID, the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities; PSMS，
Physical Self-Maintenance Scale; IADL, Lawton’s Instrumental Activities of Daily Living




Table 2.  Difference in prevalence of cognitive impairment due to severity of intellectual disability
mild ID moderate ID severe ID
Total (n) 60 135 298




SD, standard deviation; ID, intellectual disability; DS/without DS, subjects with Down syndrome and without Down
syndrome






ICD-10 DC-LD DSM-IV DSM-5†
+ + + 〇
Executive function 〇 〇
Thinking 〇 〇
Judgment 〇 〇
Other cognitive skills 〇
Information processing 〇






Emotional lability △ △
Irritability △ △
Apathy △ △
Coarsening of social behaviour △ △
 Change from premorbid state/decline in level of functioning + +
Duration of at least 6 months +
Cognitive deficits interfere with independence +
Not caused by delirium + + + +
Not caused by mental illness or physical illness + + +
†major neurocognitive disorder
+, required for diagnosis









Figure Legends  
Figure 1.  Studies of prevalences of dementia in people with 
intellectual disability without Down syndrome  
N/M, not mentioned 
 
Figure 2.  Venn diagram of differences by diagnostic criteria 
DSM-5 was able to diagnose the most cases of dementia and MCI. 
 
